Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Remdesivir Approved by FDA Experimental Antiviral Oct/15/2020 Oct/24/2020 0
Hydroxychloroquine sulfate Potential treatment - clinical evidence Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Chloroquine phosphate Recommended by China's NHC Guidelines Used to treat other disease Antiviral Sep/18/2020 Oct/10/2020 0
Azithromycin Potential treatment - clinical evidence Used to treat other disease Other treatment Sep/14/2020 Oct/05/2020 0
Heparin Potential treatment - clinical evidence Used to treat other disease Antiviral Aug/30/2020 Sep/23/2020 0
Nelfinavir mesylate Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Aug/05/2020 Sep/03/2020 0
Cepharanthine Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jul/11/2020 Sep/03/2020 0
MK-2206 Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020 Jun/22/2020 0
Auranofin Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/29/2020 Jun/01/2020 0
Niclosamide Potential treatment - pre-clinical evidence Used to treat other disease Antiviral May/27/2020 Sep/03/2020 0